Stay updated with breaking news from Acelyrin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s stock price fell 8.6% during trading on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Wall Street […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s share price was up 8% during mid-day trading on Thursday . The company traded as high as $8.24 and last traded at $8.23. Approximately 702,455 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 1,040,443 shares. The stock had previously closed […]
Acelyrin (NASDAQ:SLRN – Get Free Report) and Pfizer (NYSE:PFE – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent ratings and […]
NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that...
NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC....